MedTrace Logo

MALE Mamm Organoids

NCT06786663 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2025-01-22

No results posted yet for this study

Summary

It is believed that the use of organoids derived from male breast tumors can be of fundamental support for the definition of the molecular mechanisms underlying the onset of the tumor. Furthermore, the development of such preclinical models could be of significant support for the identification of specific personalized and ad hoc therapeutic treatments for male pathology.

Conditions

  • Breast Neoplasms, Male

Sponsors & Collaborators

  • San Giovanni Addolorata Hospital

    collaborator OTHER

  • Weizmann Institute of Science, Israel

    collaborator UNKNOWN

  • S. Andrea Hospital

    collaborator OTHER

  • Regina Elena Cancer Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-19
Primary Completion
2027-04-19
Completion
2027-04-19

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06786663 on ClinicalTrials.gov